• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前中性粒细胞与淋巴细胞比值高与结直肠癌患者生存不良相关。

A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.

机构信息

Osaka City University Graduate School of Medicine, Department of Surgical Oncology, 1-4-3 Asahi-machi Abeno-Ku Osaka City Osaka Prefecture, 545-8585, Japan.

出版信息

Anticancer Res. 2013 Aug;33(8):3291-4.

PMID:23898094
Abstract

BACKGROUND

Previous studies have reported that an elevated preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with a poor prognosis in patients with various types of cancers. The aim of this study was to determine the prognostic significance of preoperative NLR in patients with colorectal cancer and to determine an appropriate cut-off value of the NLR.

PATIENTS AND METHODS

We enrolled 674 patients who underwent surgery for stage I-IV colorectal cancer. The mean NLR was 2.74±2.20. To determine the appropriate cut-off value of the NLR, we used a receiver operating characteristic curve. A total of 262 patients with an NLR of 2.5 or more were classified as high-NLR individuals in this study. The prognostic significance of a high NLR was evaluated using a multivariate analysis.

RESULTS

The cancer-specific survival was significantly (p<0.001) worse in the patients with a high NLR. The multivariate analysis indicated that the tumor diameter, the presence of lymph node or distant metastasis, and a high NLR were independent risk factors for poor survival.

CONCLUSION

Preoperative NLR measurement is a convenient biomarker and predictor of a poor prognosis after surgery for colorectal cancer.

摘要

背景

先前的研究报告称,术前中性粒细胞与淋巴细胞比值(NLR)升高与各种类型癌症患者的预后不良有关。本研究旨在确定术前 NLR 在结直肠癌患者中的预后意义,并确定 NLR 的适当临界值。

患者与方法

我们纳入了 674 例接受 I-IV 期结直肠癌手术的患者。平均 NLR 为 2.74±2.20。为了确定 NLR 的适当临界值,我们使用了受试者工作特征曲线。在本研究中,将 NLR 为 2.5 或更高的 262 例患者归类为高 NLR 个体。使用多变量分析评估高 NLR 的预后意义。

结果

高 NLR 患者的癌症特异性生存率显著(p<0.001)较差。多变量分析表明,肿瘤直径、淋巴结或远处转移的存在以及高 NLR 是生存不良的独立危险因素。

结论

术前 NLR 测量是结直肠癌手术后预后不良的一种方便的生物标志物和预测指标。

相似文献

1
A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.术前中性粒细胞与淋巴细胞比值高与结直肠癌患者生存不良相关。
Anticancer Res. 2013 Aug;33(8):3291-4.
2
[Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer].[术前中性粒细胞与淋巴细胞比值作为IV期结直肠癌患者预后预测指标的意义]
Gan To Kagaku Ryoho. 2013 Nov;40(12):1603-5.
3
[Assessment value of preoperative neutrophil-lymphocyte ratio for the prognosis of patients with colorectal cancer after radical operation].术前中性粒细胞与淋巴细胞比值对结肠癌根治术后患者预后的评估价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Aug;16(8):723-6.
4
Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer.术前中性粒细胞与淋巴细胞比值可预测T1-2N0期结直肠癌患者的生存率。
J Surg Oncol. 2015 Nov;112(6):654-7. doi: 10.1002/jso.24061. Epub 2015 Oct 6.
5
Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation.中性粒细胞与淋巴细胞比值升高可能预示经皮射频消融治疗结直肠癌肝转移后的预后不良。
Int J Hyperthermia. 2012;28(2):132-40. doi: 10.3109/02656736.2011.654374.
6
The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer.结直肠癌患者术后全身炎症反应的预后意义。
World J Surg Oncol. 2015 Jun 4;13:194. doi: 10.1186/s12957-015-0609-3.
7
Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer.中性粒细胞与淋巴细胞比值是一种简单且新颖的生物标志物,用于预测转移性结直肠癌经放射性栓塞治疗后的生存率。
Ann Surg Oncol. 2015 May;22(5):1701-7. doi: 10.1245/s10434-014-4050-6. Epub 2014 Sep 5.
8
Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis.术前中性粒细胞与淋巴细胞比值是肝癌肝切除术后生存的预测因素:一项回顾性分析。
Ann Surg. 2013 Aug;258(2):301-5. doi: 10.1097/SLA.0b013e318297ad6b.
9
A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery.术前中性粒细胞与淋巴细胞比值为3可预测根治性择期结直肠癌手术后的无病生存期。
Ann Surg. 2014 Aug;260(2):287-92. doi: 10.1097/SLA.0000000000000216.
10
Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.可切除胰腺神经内分泌肿瘤患者术前外周血中性粒细胞/淋巴细胞比值对淋巴结转移的预测价值:一项基于列线图的研究
World J Surg Oncol. 2017 May 30;15(1):108. doi: 10.1186/s12957-017-1169-5.

引用本文的文献

1
Prognostic factors and long-term outcomes with endoscopic submucosal dissection for colorectal tumors in patients aged 75 years or older.75岁及以上患者结直肠肿瘤内镜黏膜下剥离术的预后因素及长期结局
DEN Open. 2025 May 6;6(1):e70137. doi: 10.1002/deo2.70137. eCollection 2026 Apr.
2
Preoperative blood neutrophil-to-lymphocyte ratio, hematocrit and fibrinogen predict prognosis in colorectal cancer.术前血液中性粒细胞与淋巴细胞比值、血细胞比容和纤维蛋白原可预测结直肠癌的预后。
Biomark Med. 2025 Apr;19(7):251-258. doi: 10.1080/17520363.2025.2473310. Epub 2025 Mar 4.
3
Prognostic value of systemic inflammation score in patients with esophageal cancer.
全身炎症评分在食管癌患者中的预后价值
Ann Med Surg (Lond). 2024 May 15;86(7):3852-3855. doi: 10.1097/MS9.0000000000002157. eCollection 2024 Jul.
4
Serum inflammatory markers as prognostic marker for nasopharyngeal carcinoma with liver metastasis: a multi-center retrospective study.血清炎症标志物作为伴肝转移鼻咽癌的预后标志物:一项多中心回顾性研究。
Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4315-4324. doi: 10.1007/s00405-024-08649-2. Epub 2024 Apr 20.
5
Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.结直肠癌根治术后脾密度与预后结局的相关性。
BMC Cancer. 2024 Apr 6;24(1):425. doi: 10.1186/s12885-024-12208-7.
6
Exploratory Evaluation of Pre-Treatment Inflammation Profiles in Patients with Colorectal Cancer.结直肠癌患者治疗前炎症特征的探索性评估
Diseases. 2024 Mar 20;12(3):61. doi: 10.3390/diseases12030061.
7
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.炎症指标作为接受化疗加贝伐单抗治疗的转移性结直肠癌患者的预后标志物。
Ther Adv Med Oncol. 2023 Dec 11;15:17588359231212184. doi: 10.1177/17588359231212184. eCollection 2023.
8
Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma.IV期结肠腺癌患者对曲氟尿苷/替匹嘧啶(TAS-102)三线治疗的完全缓解。
Explor Target Antitumor Ther. 2023;4(2):307-315. doi: 10.37349/etat.2023.00136. Epub 2023 Apr 27.
9
Significance of the Prognostic Immune and Nutritional Index in Patients With Stage I-III Colorectal Cancer.I-III期结直肠癌患者预后免疫和营养指数的意义
Cancer Diagn Progn. 2023 May 3;3(3):354-359. doi: 10.21873/cdp.10223. eCollection 2023 May-Jun.
10
A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index.转移性结肠癌的一种新型预后指数:预后免疫营养指数。
Cureus. 2023 Jan 15;15(1):e33808. doi: 10.7759/cureus.33808. eCollection 2023 Jan.